Metraipolis › archive › dc_4bc8f79feceb

Development and in-vivo efficacy of Leicester-UTI1 phage cocktail that targets ESBL-associated Klebsiella from urinary tract infections — Europe PMC PMID:42339862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42339862
DOI
10.1128/spectrum.03952-25
License (as archived)
solo-consultazione
Archived
2026-10-07T16:51:18.365Z
SHA-256 of the archived text
0d7efe53de081f95d52155354115818fb58b03ed248a0de3ede64a16289625c5
Stable URL of this page
https://metraipolis.com/documento/dc_4bc8f79feceb

How to cite

Development and in-vivo efficacy of Leicester-UTI1 phage cocktail that targets ESBL-associated Klebsiella from urinary tract infections — Europe PMC PMID:42339862 — Europe PMC (en), https://europepmc.org/article/MED/42339862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bc8f79feceb (Metraipolis archive dc_4bc8f79feceb, sha256 0d7efe53de081f95d52155354115818fb58b03ed248a0de3ede64a16289625c5)
BibTeX
@misc{dc4bc8f79feceb,
  title = {Development and in-vivo efficacy of Leicester-UTI1 phage cocktail that targets ESBL-associated Klebsiella from urinary tract infections — Europe PMC PMID:42339862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42339862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bc8f79feceb; sha256 0d7efe53de081f95d52155354115818fb58b03ed248a0de3ede64a16289625c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42339862. Agents can read the archived copy with the MCP tool read_document.